Genetic variants in nuclear factor-kappa B binding sites are associated with clinical outcomes in prostate cancer patients.

Abstract excerpt

Nuclear factor-kappa B (NF-κB) transcription factors have been suggested to be involved in prostate cancer progression. Activated NF-κB translocates to the nucleus, binds to NF-κB binding sites and regulates target gene expression, leading to the given physiological response. It was hypothesised that the sequence variants in NF-κB binding sites might affect prostate cancer progression. We systematically evaluated...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cohort Studies
• Share to Intracellular Signaling Peptides and Proteins